Navigation Links
Aspirin-like compounds increase insulin secretion in otherwise healthy obese people
Date:4/28/2008

Aspirin-like compounds (salicylates) can claim another health benefit: increasing the amount of insulin produced by otherwise healthy obese people. Obesity is associated with insulin resistance, the first step toward type 2 diabetes.

Aspirin and other salicylates are known to reduce blood glucose in diabetic patients. New research accepted for publication in the Journal of Clinical Endocrinology & Metabolism reveals a similar beneficial effect among obese individuals by increasing the amount of insulin secreted into the bloodstream.

The administration of a salicylate led to the lowering of serum glucose concentrations, said Jose-Manuel Fernandez-Real of the Institut dInvestigacio Biomedica de Girona and CIBEROBN Fisiopatologia de la Obesidad, Spain, and lead author of the study. These findings highlight the importance of further research on the possible therapeutic benefit of aspirin in the fight against type 2 diabetes.

For their study, Fernandez-Real and his colleagues evaluated the effects of triflusal (a derivative of salicylate) on 28 subjects (nine men and 29 women). The average age of the participants was 48 years old and their average Body Mass Index (BMI) was 33.9. A BMI of over 30 is considered obese. During three, four-week treatment periods, the study participants received a 600 mg dose, a 900 mg dose, or a placebo once per day.

The researchers found that administration of triflusal led to decreased fasting serum glucose. Contrary to their expectations, insulin sensitivity did not significantly change during the trial. Insulin secretion, however, significantly increased in relation to the dose size.

In conjunction with the human studies, the researchers also conducted laboratory studies on insulin-producing cells (known as islets of Langerhans) from mice and humans. The researchers observed that triflusal significantly increased the insulin secreted by these cells.

Aspirin therapy has been rec
'/>"/>

Contact: Charles Blue
cblue@endo-society.org
301-941-0240
The Endocrine Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
2. Organon Signs an Exclusive, Worldwide Licence Agreement on Advanced Antithrombotic Compounds With Endotis Pharma
3. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
4. Novel Compounds May Battle Diseases of Aging
5. Bionovo Describes a New Class of Therapeutic Compounds
6. Active compounds found in Ganoderma lucidum fungus with potential to treat prostate cancer
7. Research discovers new compounds active against tuberculosis and malaria
8. Researcher of the University of Navarra discovered potential antidepressant compounds
9. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
10. Stevens chemists identify compounds to lure nutria, a rat-like pest ravaging Gulf Coast wetlands
11. Drosophila drug screen for fragile X syndrome finds promising compounds and potential drug targets

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...nis & Ennis, P.A. is offering free nationwide ...smin birth control pills who have suffered a Deep ... Heart Attack or other related cardiac issues or h...free at 1-800-856-6405 or go to the firm’s w...n online case evaluation form. , ...
(Date:11/25/2009)...5/PRNewswire/--TheBartleHallConventionCenterwillte...c.9-10,whenKansasCityhoststhelatestinaseriesofmass...liniceventhasthepotentialtobethebiggestoneyet,beca...donweekdaysinsteadofoveraweekend,"SheriWood,execut...dentoftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...v.25/PRNewswire/-SentinelleMedicalInc.,aleadingman...ftwareandCalgaryScientificInc.,aleadingproviderofs...ionofAegis(TM)Breast4DAdvancedVisualizationsoftwar...o-footprintWebclientbasedmedicalimagingofferingint...owsforzero-footprintaccess-requiringnosoftwaredown...
(Date:11/25/2009)....25/PRNewswire/--Thanksgivingmealswillbedeliveredt...gBeachareathankstoFaithInAction/VolunteerActionfor...ivisionofSCANHealthPlan.Formorethan17yearstheseorg...rwarmThanksgivingmealstoseniorsinneedinLongBeach,L...oundingcities. ,, "Ourwarmholidaymealsaredelive...
(Date:11/25/2009)...Newswire-USNewswire/--TheBlackAIDSInstituterecentl...eadershipfor2010. ,, ThenewBoardMembersareahigh...cy,law,finance,governmenthealthprograms,editorial,...widerangeofpersonalbackgroundsincludingbothheteros...elves,andrepresentingmultipleagegroups. ,, (Pho...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...er 30, 2008,viewers tuning in to the new CBS dayti...m ) will find hope for stuttering. That day, the,D...er, M.A., CCC-SP,founder of Power Stuttering Cente...recognized stuttering specialist, overcame his own...
... outcomes, but offers no concrete answers , ...mericans who live in low-income ZIP codes are more...n higher-income ZIP codes, according to new resear...99 and 2003. , The risk of death was between 17 p...
...,Inc. (Nasdaq: HRLY ) announced today that its He..., has a contract totaling approximately $1.3 milli..., NY, for the manufacture of,complex switch filter... new,primary maritime-dominance helicopter, replac...
...l-service,provider of public relations, investor r...trategy to life science clients, today announced t...y of record by cancer therapeutics,company, Neotro...company,s,clinical development. Neuroendocrine can...
...ent Specialists signs agreement with PureWellness .... , Burlington, VT (PRWEB...g provider of online wellness solutions, announced... living communities across the country. , , ,&quo...
...tanford University School of ,Medicine have found ...ivity of individual proteins in cells and living m...for identifying more precisely than ever ,before ...e selectively delivered to tumors. , The procedur...
Other Medicine News:Health News:Help for Stutterers on 'The Doctors' TV Show Presented by Power Stuttering Center Founder Mark Power 2Health News:Seniors in Poor Areas More Likely to Die After Surgery 2Health News:Herley New England Receives Additional $1.3 Million Contract Award from Lockheed Martin for the Multi-Mission Helicopter 2Health News:LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster 2Health News:Nation's Leading Food Services Provider Chooses PureWellness to Drive Corporate Wellness Program 2Health News:New way to control protein activity could lead to cancer therapies 2Health News:New way to control protein activity could lead to cancer therapies 3
(Date:11/25/2009)...v.25/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq...tedtodiscovering,developingandcommercializingnovel...tsforthefiscalyearendedSeptember30,2009.AtSeptembe...alentsandshortterminvestments. ,, PipelineUpda...bTrial ,, InlateNovember2009,anindependentDat...
(Date:11/25/2009)...PRNewswire/--BioTrendsResearchGroup,Inc.releasedWa...firstinamulti-phasesyndicatedmarketresearchproject...fromproductlaunchthroughthefirstsixmonthsofavailab...mationfrom75uniqueDermatologistsandqualitativeinfo...ofStelara,obstaclestouse,typicalpatienttypes,produ...
(Date:11/25/2009)...ov.25/PRNewswire-USNewswire/--RemediumTechnologies...topsseverebleeding,wonfirstprizeand$10,000intheMos...hallenge2009,companyofficialsannouncetoday. ,, ...emedium,steampitchedtheirinventionattheGSCSecurity..., Remedium( www.remediumtechnologies.com )isdev...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Stop Smoking Vaccine in the Works 59295 1Stop Smoking Vaccine in the Works 59295 2Gary C Baker Named KePRO Chief Financial Officer 59292 1Gary C Baker Named KePRO Chief Financial Officer 59292 2Gary C Baker Named KePRO Chief Financial Officer 59292 3Cosmetic Bootcamp University New York Deemed A Huge Success 59289 1
...est study to examine,the effect of depression on H...orsens a patient,s adherence to highly active anti... effective antidepressant medication,can reverse t...rmanente,Division of Research and the Group Health... of the Journal of Acquired Immune Deficiency Synd...
...Therapies, Inc. (ITI),today announced it has initi...inical study using its drug candidate ITI-722. ITI...ptor antagonist and represents an important new,ap...el separation of 5-HT2A,and dopamine receptor modu...ed not only to treat SMI but it may be highly appr...
Other Medicine Technology:Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment 2Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment 3Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 2Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 3Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 4
Schuknecht-Weitlaner Retractor
Blunt Weitlaner Retractor
Weitlaner Beckmann Retractor
Baby Weitlaner Retractor
Medicine Products: